IL2 and neoplasm: WT, Tbx21−/−, or Zeb2−/− KP.SIY lung tumor-bearing mice were treated with MSA-IL2 and MSA-IL12 (alone or in combination) on day 7 of tumor growth and monitored daily for survival (Fig. 7a).